David Lawrence
CIK 1272353 · Chief, Bus. Ops & PAO · last filed 2020-12-03
David Lawrence is a Chief, Bus. Ops & PAO who has filed 72 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider had shares withheld for taxes covering $738 of ACOR on Dec 3, 2020. Across all open-market trades the lifetime net is −$11.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACOR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief, Bus. Ops & PAO | 115 | $0.66 | $76 | -$11.14M | 72 | 2020-12-03 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Tax (F) | −1,141 | -$738 | EDGAR |
| 2020-11-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Tax (F) | −1,024 | -$881 | EDGAR |
| 2020-09-21 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +3,015 | $0 | EDGAR |
| 2019-12-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −1,176 | -$1.9K | EDGAR |
| 2019-11-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +9,045 | $0 | EDGAR |
| 2019-02-25 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −761 | -$10.0K | EDGAR |
| 2018-12-27 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +2,200 | $0 | EDGAR |
| 2018-12-06 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −2,493 | -$51.2K | EDGAR |
| 2018-11-07 | Acorda Therapeutics, Inc. (ACOR) Delisted | Tax (F) | −747 | -$15.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.